Navigation Links
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Date:8/6/2012

Therapeutics Market, Germany, Revenue ($m), 2006- 2011 29

Table 12: Retinal Vein Occlusion Therapeutics Market, Germany, Forecasts ($m), 2011- 2019 30

Table 13: Retinal Vein Occlusion Therapeutics Market, Italy, Revenue ($m), 2006- 2011 31

Table 14: Retinal Vein Occlusion Therapeutics Market, Italy, Forecasts ($m), 2011- 2019 32

Table 15: Retinal Vein Occlusion Therapeutics Market, Spain, Revenue ($m), 2006- 2011 33

Table 16: Retinal Vein Occlusion Therapeutics Market, Spain, Forecasts ($m), 2011- 2019 34

Table 17: Retinal Vein Occlusion Therapeutics Market, The UK, Revenue ($m), 2006- 2011 35

Table 18: Retinal Vein Occlusion Therapeutics Market, The UK, Forecasts ($m), 2011- 2019 36

Table 19: Retinal Vein Occlusion Therapeutics Market, Japan, Revenue ($m), 2006- 2011 37

Table 20: Retinal Vein Occlusion Therapeutics Market, Japan, Forecasts ($m), 2011- 2019 38

Table 21: Lucentis Phase III Clinical Trial Details 43

Table 22: Number (%) of Patients With ? 15 Letter Improvement from Baseline in Best-Corrected Visual Acuity 44

Table 23: Adverse Reactions Reported by >2% of Patients in the First Six Months 44

Table 24: Retinal Vein Occlusion Therapeutics, Phase III Pipeline, 2012 47

Table 25: Retinal Vein Occlusion Therapeutics, Phase II/III Pipeline, 2012 47

Table 26: Retinal Vein Occlusion Therapeutics, Phase II Pipeline, 2012 48

Table 27: Retinal Vein Occlusion Therapeutics, Phase I/II Pipeline, 2012 48

Table 28: RVO Therapeutics - Most Promising Drugs Under Clinical Development, 2012 51

Table 29: Eylea Phase III Clinical Trial Details 53

Table 30: Retinal Vein Occlusion Therapeutics, Clinical Trials by Country, 2012 54

Table 31: Retinal Vein Occlusion Therapeutics, Clinical Trials by Phase, 2012 55

Table 32: Retinal Vein Occlusion Therapeutics, Clinical Trials by Status, 2012 56

Table 33: Retinal Vein Occlusion
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
4. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
5. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
6. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
7. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014  Dr. Mark Rasak , MD ... Lifetime Achievement Award in the field of Medicine as ... Clinical Associates. Dr. Rasak has over 15 ... aspects of the business; overseeing the daily operations; interventional ... intervention. In addition, he is an honored Fellow of ...
(Date:8/22/2014)... , Aug. 22, 2014 Research and ... "Global and Chinese Particulate Respirators Industry Report 2014" ... and Chinese Particulate Respirators Industry Report 2014 is a ... the global particulate respirators industry with a focus on ... overview of the industry including definitions, classifications, applications and ...
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, Inc. ... formulation-based drug development and related consulting, is pleased ... international medical cannabis conference taking place at the ... , on October 22, 2014.  The multilingual ... such as researchers, health professionals, and patients, to ...
Breaking Medicine Technology:Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Global and Chinese Particulate Respirators Industry Report 2014 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3
... annual open enrollment season begins for Medicare Part ... to answer questions and provide guidance on how ... December 7, Medicare beneficiaries have the opportunity to ... a new plan, if they so choose. ...
... 14, 2011 Intellect Neurosciences, Inc. (OTCBB: ILNS), a ... disease-modifying therapeutic agents for the treatment of Alzheimer,s and ... Shareholders from Dr. Daniel Chain, Chairman and CEO. ... take this opportunity to update you about pertinent corporate ...
Cached Medicine Technology:CVS/pharmacy Ready to Provide Assistance During Medicare Part D Annual Enrollment Period 2Intellect Neurosciences Issues Letter to Shareholders 2Intellect Neurosciences Issues Letter to Shareholders 3Intellect Neurosciences Issues Letter to Shareholders 4Intellect Neurosciences Issues Letter to Shareholders 5Intellect Neurosciences Issues Letter to Shareholders 6Intellect Neurosciences Issues Letter to Shareholders 7Intellect Neurosciences Issues Letter to Shareholders 8Intellect Neurosciences Issues Letter to Shareholders 9
(Date:8/22/2014)... complex autoimmune disease that affects 1 to 2 ... cope with pain, disability and joint disfigurements, but ... life and marital functioning. While many pharmacological advances ... is common. In addition, some patients avoid newer ... effects. Because of this, there is interest in ...
(Date:8/22/2014)... Eagerly embracing intended parents around the globe, ... offers the top male infertility programs — run by ... network of IVFinMexico.com continues to shape modern ... female and male infertility, advanced research and education. , ... eminently set by company CEO and Founder Tolga Umar ...
(Date:8/22/2014)... time provides an opportunity for parents to develop an ... expert suggests. "Forget New Year,s resolutions; the start ... start of a new fitness and exercise program for ... University of the Sciences in Philadelphia, said in a ... to build up, "it,s important for mom and dad ...
(Date:8/22/2014)... again attained the distinguished Magnet hospital designation by ... Program. Considered the gold standard for nursing excellence, ... and professionalism. It is the top international credential ... redesignate Newport Hospital was based on the hospital,s ... practice. , "It is a privilege for us ...
(Date:8/22/2014)... News) -- Many children get anxious or afraid when ... a number of ways that parents can make these ... The first step is to explain to children in ... health, said Rita John, director of the pediatric primary ... Nursing in New York City. "Children need to ...
Breaking Medicine News(10 mins):Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4Health News:With Kids in School, Parents Can Work Out 2Health News:Newport Hospital receives nursing's highest credential for third time with Magnet recognition 2Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2
... Rochelle, NY, November 1, 2011Clinicians often face the challenge ... parents, teachers, and children about a child,s behavioral problems. ... of these disagreements may provide important information that could ... the current issue of Journal of Child and ...
... take aspirin for a headache, thank a willow tree. ... found in willow tree bark and is made by ... mimicking the chemical production processes of plants, scientists have ... alkaloid drug products, including caffeine, atropine (an anti-spasmodic used ...
... million expanded initiative sponsored by the National Institutes of ... cardiovascular disease and to assess potential new treatments in ... Americans have diabetes, the seventh leading cause of death ... of heart disease, stroke, kidney disease, blindness and amputation. ...
... undergoing percutaneous coronary intervention (PCI), also known as ... than men. Risk-adjusted analyses have now indicated that, ... independent mortality predictor following PCI according to the ... Interventions , a journal published by Wiley-Blackwell on ...
... recent study published in the November issue of the ... many radiologists disagree on the management of incidental findings ... finding is something found that is unrelated to the ... in CT resolution have improved radiologists, ability to identify ...
... of a study being published online Oct. 31, 2011, in the ... women who carry mutations in a BRCA gene - but who ... an increased risk of developing breast cancer compared to relatives of ... results run counter to a previous study showing a higher risk ...
Cached Medicine News:Health News:Conflicting views of a child's behavior problems from parents, teachers, and the child may be helpful to clinician 2Health News:Plant researchers locate transporter used for nicotine metabolism 2Health News:ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment 2Health News:ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment 3Health News:Women undergoing PCI display greater number of co-morbidities than men 2Health News:Study shows no increased risk of breast cancer for non-carriers in families with BRCA gene mutation 2Health News:Study shows no increased risk of breast cancer for non-carriers in families with BRCA gene mutation 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: